ASCO
Industry Voice
At a recent American Society for Clinical Oncology (ASCO) conference investors were able to review progress in immunotherapy clinical trials. The progress is positive. Incyte, for one, presented improved patient response rates in five types of cancer...
Sponsored
10 July 2017
•
1 min read
10 July 2017
•
1 min read
